AAP IMPLANTATE AG.
AAQ1.XETRA | Manufacture of medical and dental instruments and supplies
AAP Implantate AG, based in Berlin, Germany, develops, manufactures, and distributes innovative trauma and orthopedic implants and related instruments. The company focuses on biomaterial-based implants, particularly its LOQTEQ® system for fracture fixation. Their product portfolio includes solutions...Show More
Better Health for All
-10
The company's core business focuses on trauma and orthopedic implants, aiming to improve patient mobility and quality of life through innovative products, indicating that its entire business is devoted to health improvement.
1
In 2013, the company allocated 8% of its sales to R&D, which is directed towards improving health outcomes.
2
The company also provides training to emergency surgeons and other medical professionals on its LOQTEQ® implants.
3
Fair Money & Economic Opportunity
0
No evidence available to assess AAP IMPLANTATE AG on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
The provided articles do not contain specific, concrete data points for any of the KPIs under the 'Fair Pay & Worker Respect' value for AAP Implantate AG.
1
Multiple articles explicitly state the absence of information regarding living wages, CEO-to-median employee pay ratios, collective bargaining, safety incident rates, pay equity, worker engagement, turnover rates, labor violations, insecure contract shares, or health insurance coverage for the company.
2
Fair Trade & Ethical Sourcing
0
No specific, quantitative evidence for AAQ1.XETRA regarding fair trade and ethical sourcing practices was found in the provided articles. The articles either discuss general industry concepts, policies of other companies, or codes of conduct without performance data for AAQ1.XETRA.
Honest & Fair Business
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Honest & Fair Business. While articles mention audit impediments for the 2023 financial statements and a 'threat of a six-figure penalty payment' for publishing unaudited financials, there is no evidence that any fines were actually levied or paid.
1
The articles do not provide information on transparency index scores, whistleblower policy details, financial restatements, audit coverage percentages, ESG controversy scores, complaint resolution times, board conflict-free percentages, anti-corruption policy strength and enforcement, or third-party verification of ethical claims.
Kind to Animals
0
No evidence available to assess AAP IMPLANTATE AG on Kind to Animals.
No War, No Weapons
0
No evidence available to assess AAP IMPLANTATE AG on No War, No Weapons.
Planet-Friendly Business
0
The provided articles focus on AAP Implantate AG's financial performance, product technology, and regulatory approvals for medical devices. There is no specific, concrete data available in the articles regarding any of the 'Planet-Friendly Business' KPIs, such as greenhouse gas emissions, renewable energy use, water consumption, waste management, climate targets, or environmental impact assessments.
1
Therefore, no KPIs can be scored based on the evidence provided.
Respect for Cultures & Communities
0
No specific, factual data points were found in the provided articles to assess AAP Implantate AG against any of the KPIs for 'Respect for Cultures & Communities'. The articles primarily focus on financial performance, regulatory certifications, and job openings, without mentioning community engagement, cultural impact, or related initiatives.
1
Safe & Smart Tech
-20
The company explicitly states compliance with GDPR and outlines user rights including information, correction, deletion, restriction, transfer, and objection.
1
It also states that data will be deleted or restricted when no longer required or subject to legal retention.
2
However, specific mechanisms for user data control are not detailed.
3
The company holds an active EU-U.S. Privacy Shield certification, but this framework was invalidated in July 2020, making it an expired certification for its intended purpose.
4
Zero Waste & Sustainable Products
0
No specific, concrete evidence was found in the provided articles to assess AAP Implantate AG against any of the Key Performance Indicators for Zero Waste & Sustainable Products. Information regarding waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education was not present. A mention of a 'resorbable magnesium implant, launch planned 2016' is a forward-looking statement and cannot be used as evidence of current or past action.
1